Recent Finacing
Recent Raise
Regenxbio is a gene-therapy biotech that uses proprietary NAV® AAV technology to develop and license treatments for CNS, retinal and liver diseases while advancing clinical programs and manufacturing infrastructure.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
